REFERENCES:
1. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2
infection: a nationwide analysis in China. The Lancet Oncology.2020;21(3):335-337.
2. Zhang L, Zhu F, Xie L, et al. Clinical characteristics of
COVID-19-infected cancer patients: A retrospective case study in three
hospitals within Wuhan, China. Annals of oncology : official
journal of the European Society for Medical Oncology. 2020.
3. Baxi SS, Pinheiro LC, Patil SM, Pfister DG, Oeffinger KC, Elkin EB.
Causes of death in long-term survivors of head and neck cancer.Cancer. 2014;120(10):1507-1513.
4. Ferrier MB, Spuesens EB, Le Cessie S, Baatenburg de Jong RJ.
Comorbidity as a major risk factor for mortality and complications in
head and neck surgery. Archives of otolaryngology–head & neck
surgery. 2005;131(1):27-32.
5. Francis DO, Weymuller EA, Jr., Parvathaneni U, Merati AL, Yueh B.
Dysphagia, stricture, and pneumonia in head and neck cancer patients:
does treatment modality matter? The Annals of otology, rhinology,
and laryngology. 2010;119(6):391-397.
6. Kawakita D, Abdelaziz S, Chen Y, et al. Adverse respiratory outcomes
among head and neck cancer survivors in the Utah Cancer Survivors Study.Cancer. 2020;126(4):879-885.
7. Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK. Population-based study of
competing mortality in head and neck cancer. Journal of clinical
oncology : official journal of the American Society of Clinical
Oncology. 2011;29(26):3503-3509.
8. Shen W, Sakamoto N, Yang L. Cancer-specific mortality and competing
mortality in patients with head and neck squamous cell carcinoma: a
competing risk analysis. Annals of surgical oncology.2015;22(1):264-271.
9. Sucharew H, Macaluso M. Progress Notes: Methods for Research Evidence
Synthesis: The Scoping Review Approach. Journal of hospital
medicine. 2019;14(7):416-418.
10. Couch RB, Englund JA, Whimbey E. Respiratory viral infections in
immunocompetent and immunocompromised persons. The American
journal of medicine. 1997;102(3a):2-9; discussion 25-26.
11. Rolston KV. The spectrum of pulmonary infections in cancer patients.Current opinion in oncology. 2001;13(4):218-223.
12. Stover DE, Kaner RJ. Pulmonary complications in cancer patients.CA: a cancer journal for clinicians. 1996;46(5):303-320.
13. Kamboj M, Sepkowitz KA. Nosocomial infections in patients with
cancer. The Lancet Oncology. 2009;10(6):589-597.
14. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia.Lancet (London, England). 2011;377(9773):1264-1275.
15. Ueda M, Martins R, Hendrie PC, et al. Managing Cancer Care During
the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal.Journal of the National Comprehensive Cancer Network : JNCCN.2020:1-4.
16. Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in
Italy. Jama. 2020.
17. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and
Characteristics of Patients Dying in Relation to COVID-19 in Italy.Jama. 2020.
18. WHO. Report of the WHO-China Joint Mission on Coronavirus Disease
2019 (COVID-19).
https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.
Accessed April 12, 2020.
19. Wang H, Zhang L. Risk of COVID-19 for patients with cancer.The Lancet Oncology. 2020.
20. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: a descriptive study. Lancet (London, England).2020;395(10223):507-513.
21. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138
Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in
Wuhan, China. Jama. 2020.
22. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for
mortality of adult inpatients with COVID-19 in Wuhan, China: a
retrospective cohort study. Lancet (London, England).2020;395(10229):1054-1062.
23. Lei S JF, Su W, et al. Clinical characteristics and outcomes of
patients undergoing surgeries during the incubation period of COVID-19
infection. EClinicalMedicine. 2020.
https://doi.org/10.1016/j.eclinm.2020.100331.
24. Semenov YR, Starmer HM, Gourin CG. The effect of pneumonia on
short-term outcomes and cost of care after head and neck cancer surgery.The Laryngoscope. 2012;122(9):1994-2004.
25. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and
mortality worldwide for 36 cancers in 185 countries. CA: a cancer
journal for clinicians. 2018;68(6):394-424.
26. Argiris A, Brockstein BE, Haraf DJ, et al. Competing causes of death
and second primary tumors in patients with locoregionally advanced head
and neck cancer treated with chemoradiotherapy. Clinical cancer
research : an official journal of the American Association for Cancer
Research. 2004;10(6):1956-1962.
27. Mell LK, Dignam JJ, Salama JK, et al. Predictors of competing
mortality in advanced head and neck cancer. Journal of clinical
oncology : official journal of the American Society of Clinical
Oncology. 2010;28(1):15-20.
28. Montero-Miranda PH, Ganly I. Survivorship–competing mortalities,
morbidities, and second malignancies. Otolaryngologic clinics of
North America. 2013;46(4):681-710.
29. Piccirillo JF, Vlahiotis A. Comorbidity in patients with cancer of
the head and neck: prevalence and impact on treatment and prognosis.Current oncology reports. 2006;8(2):123-129.
30. Landis SH, El-Hariry IA, van Herk-Sukel MP, et al. Prevalence and
incidence of acute and chronic comorbidity in patients with squamous
cell carcinoma of the head and neck. Head & neck.2012;34(2):238-244.
31. Piccirillo JF. Importance of comorbidity in head and neck cancer.The Laryngoscope. 2015;125(10):2242.
32. Ostroff JS, Jacobsen PB, Moadel AB, et al. Prevalence and predictors
of continued tobacco use after treatment of patients with head and neck
cancer. Cancer. 1995;75(2):569-576.
33. Smith J, Nastasi D, Tso R, Vangaveti V, Renison B, Chilkuri M. The
effects of continued smoking in head and neck cancer patients treated
with radiotherapy: A systematic review and meta-analysis.Radiotherapy and oncology : journal of the European Society for
Therapeutic Radiology and Oncology. 2019;135:51-57.
34. Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking
on the efficacy of radiation therapy in head and neck cancer. The
New England journal of medicine. 1993;328(3):159-163.
35. van Imhoff LC, Kranenburg GG, Macco S, et al. Prognostic value of
continued smoking on survival and recurrence rates in patients with head
and neck cancer: A systematic review. Head & neck. 2016;38 Suppl
1:E2214-2220.
36. Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco
and alcohol use and the risk of head and neck cancer: pooled analysis in
the International Head and Neck Cancer Epidemiology Consortium.Cancer epidemiology, biomarkers & prevention : a publication of
the American Association for Cancer Research, cosponsored by the
American Society of Preventive Oncology. 2009;18(2):541-550.
37. Giraldi L, Leoncini E, Pastorino R, et al. Alcohol and cigarette
consumption predict mortality in patients with head and neck cancer: a
pooled analysis within the International Head and Neck Cancer
Epidemiology (INHANCE) Consortium. Annals of oncology : official
journal of the European Society for Medical Oncology.2017;28(11):2843-2851.
38. Spitz MR, Fueger JJ, Chamberlain RM, Goepfert H, Newell GR.
Cigarette smoking patterns in patients after treatment of upper
aerodigestive tract cancers. Journal of cancer education : the
official journal of the American Association for Cancer Education.1990;5(2):109-113.
39. Bhattacharyya N, Fried MP. Benchmarks for mortality, morbidity, and
length of stay for head and neck surgical procedures. Archives of
otolaryngology–head & neck surgery. 2001;127(2):127-132.
40. Buitelaar DR, Balm AJ, Antonini N, van Tinteren H, Huitink JM.
Cardiovascular and respiratory complications after major head and neck
surgery. Head & neck. 2006;28(7):595-602.
41. Manikantan K, Khode S, Sayed SI, et al. Dysphagia in head and neck
cancer. Cancer treatment reviews. 2009;35(8):724-732.
42. Mets OM, Buckens CF, Zanen P, et al. Identification of chronic
obstructive pulmonary disease in lung cancer screening computed
tomographic scans. Jama. 2011;306(16):1775-1781.
43. Ohashi Y, Nakai Y, Ikeoka H, et al. Functional and morphological
pathology of the nasal mucosa after x-ray irradiation. Clin
Otolaryngol Allied Sci. 1988;13(6):435-446.
44. Lou PJ, Chen WP, Tai CC. Delayed irradiation effects on nasal
epithelium in patients with nasopharyngeal carcinoma. An ultrastructural
study. The Annals of otology, rhinology, and laryngology.1999;108(5):474-480.
45. Ohyama MM, Y.; Yamamoto, S.; Fujita, T.; Taniguchi, T. Surface
ultrastructure of pathological mucosa of the human larynx.Otologica Fukuoka. 1977;23:646-659.
46. Stringer SP, Stiles W, Slattery WH, 3rd, et al. Nasal mucociliary
clearance after radiation therapy. The Laryngoscope. 1995;105(4
Pt 1):380-382.
47. Surico G, Muggeo P, Mappa L, et al. Impairment of nasal mucociliary
clearance after radiotherapy for childhood head cancer. Head &
neck. 2001;23(6):461-466.
48. Alon EE, Lipschitz N, Bedrin L, et al. Delayed Sino-nasal
Complications of Radiotherapy for Nasopharyngeal Carcinoma.Otolaryngology–head and neck surgery : official journal of
American Academy of Otolaryngology-Head and Neck Surgery.2014;151(2):354-358.
49. Brown LR, Dreizen S, Handler S, Johnston DA. Effect of
radiation-induced xerostomia on human oral microflora. Journal of
dental research. 1975;54(4):740-750.
50. Himi T, Kukuminato Y, Kita H, Yoshioka I, Kataura A. Effect of
radiotherapy on the levels of secretory immunoglobulin A against
indigenous and virulent streptococci. Otolaryngology–head and
neck surgery : official journal of American Academy of
Otolaryngology-Head and Neck Surgery. 1997;117(5):433-437.
51. Sturgis EM, Wei Q, Spitz MR. Descriptive epidemiology and risk
factors for head and neck cancer. Semin Oncol.2004;31(6):726-733.
52. Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells of
the respiratory tract. Thorax. 1994;49(8):825-834.
53. Arcavi L, Benowitz NL. Cigarette smoking and infection.Archives of internal medicine. 2004;164(20):2206-2216.
54. Hussain M, Kish JA, Crane L, et al. The role of infection in the
morbidity and mortality of patients with head and neck cancer undergoing
multimodality therapy. Cancer. 1991;67(3):716-721.
55. Mirabile A, Vismara C, Crippa F, et al. Health care-associated
infections in patients with head and neck cancer treated with
chemotherapy and/or radiotherapy. Head & neck. 2016;38 Suppl
1:E1009-1013.
56. Merlano MC, Monteverde M, Colantonio I, et al. Impact of age on
acute toxicity induced by bio- or chemo-radiotherapy in patients with
head and neck cancer. Oral oncology. 2012;48(10):1051-1057.
57. Winther B. Rhinovirus infections in the upper airway.Proceedings of the American Thoracic Society. 2011;8(1):79-89.
58. Dandachi D, Rodriguez-Barradas MC. Viral pneumonia: etiologies and
treatment. Journal of investigative medicine : the official
publication of the American Federation for Clinical Research.2018;66(6):957-965.
59. Seki M, Kosai K, Yanagihara K, et al. Disease severity in patients
with simultaneous influenza and bacterial pneumonia. Internal
medicine (Tokyo, Japan). 2007;46(13):953-958.
60. Klein EY, Monteforte B, Gupta A, et al. The frequency of influenza
and bacterial coinfection: a systematic review and meta-analysis.Influenza and other respiratory viruses. 2016;10(5):394-403.
61. Sepehr A, Santos BJ, Chou C, et al. Antibiotics in head and neck
surgery in the setting of malnutrition, tracheotomy, and diabetes.The Laryngoscope. 2009;119(3):549-553.
62. Panghal M, Kaushal V, Kadayan S, Yadav JP. Incidence and risk
factors for infection in oral cancer patients undergoing different
treatments protocols. BMC oral health. 2012;12:22.
63. Bartlett JG. Anaerobic bacterial infection of the lung.Anaerobe. 2012;18(2):235-239.
64. Langerman A, Maccracken E, Kasza K, Haraf DJ, Vokes EE, Stenson KM.
Aspiration in chemoradiated patients with head and neck cancer.Archives of otolaryngology–head & neck surgery.2007;133(12):1289-1295.
65. Shirasu H, Yokota T, Hamauchi S, et al. Risk factors for aspiration
pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for
head and neck cancer. BMC cancer. 2020;20(1):182.
66. Kawai S, Yokota T, Onozawa Y, et al. Risk factors for aspiration
pneumonia after definitive chemoradiotherapy or bio-radiotherapy for
locally advanced head and neck cancer: a monocentric case control study.BMC cancer. 2017;17(1):59.
67. Chu CN, Muo CH, Chen SW, Lyu SY, Morisky DE. Incidence of pneumonia
and risk factors among patients with head and neck cancer undergoing
radiotherapy. BMC cancer. 2013;13:370.
68. Hunter KU, Lee OE, Lyden TH, et al. Aspiration pneumonia after
chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma
and its clinical and dysphagia-related predictors. Head & neck.2014;36(1):120-125.
69. Mortensen HR, Jensen K, Grau C. Aspiration pneumonia in patients
treated with radiotherapy for head and neck cancer. Acta
oncologica (Stockholm, Sweden). 2013;52(2):270-276.
70. Nguyen NP, Frank C, Moltz CC, et al. Aspiration rate following
chemoradiation for head and neck cancer: an underreported occurrence.Radiotherapy and oncology : journal of the European Society for
Therapeutic Radiology and Oncology. 2006;80(3):302-306.
71. Chen SW, Yang SN, Liang JA, Lin FJ. The outcome and prognostic
factors in patients with aspiration pneumonia during concurrent
chemoradiotherapy for head and neck cancer. European journal of
cancer care. 2010;19(5):631-635.
72. Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of
swallowing dysfunction and aspiration after radiation concurrent with
chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol
Phys. 2002;53(1):23-28.
73. Komiya K, Ishii H, Umeki K, et al. Impact of aspiration pneumonia in
patients with community-acquired pneumonia and healthcare-associated
pneumonia: a multicenter retrospective cohort study. Respirology
(Carlton, Vic). 2013;18(3):514-521.
74. Lanspa MJ, Jones BE, Brown SM, Dean NC. Mortality, morbidity, and
disease severity of patients with aspiration pneumonia. Journal of
hospital medicine. 2013;8(2):83-90.
75. Xu B, Boero IJ, Hwang L, et al. Aspiration pneumonia after
concurrent chemoradiotherapy for head and neck cancer. Cancer.2015;121(8):1303-1311.
76. Chang CC, Lee WT, Hsiao JR, et al. Oral hygiene and the overall
survival of head and neck cancer patients. Cancer medicine.2019;8(4):1854-1864.
77. Farquhar DR, Divaris K, Mazul AL, Weissler MC, Zevallos JP, Olshan
AF. Poor oral health affects survival in head and neck cancer.Oral oncology. 2017;73:111-117.
78. Friemel J, Foraita R, Gunther K, et al. Pretreatment oral hygiene
habits and survival of head and neck squamous cell carcinoma (HNSCC)
patients. BMC oral health. 2016;16:33.
79. Hashim D, Sartori S, Brennan P, et al. The role of oral hygiene in
head and neck cancer: results from International Head and Neck Cancer
Epidemiology (INHANCE) consortium. Annals of oncology : official
journal of the European Society for Medical Oncology.2016;27(8):1619-1625.
80. Zeng XT, Leng WD, Zhang C, Liu J, Cao SY, Huang W. Meta-analysis on
the association between toothbrushing and head and neck cancer.Oral oncology. 2015;51(5):446-451.
81. Sjogren P, Nilsson E, Forsell M, Johansson O, Hoogstraate J. A
systematic review of the preventive effect of oral hygiene on pneumonia
and respiratory tract infection in elderly people in hospitals and
nursing homes: effect estimates and methodological quality of randomized
controlled trials. Journal of the American Geriatrics Society.2008;56(11):2124-2130.
82. Sjogren P, Wardh I, Zimmerman M, Almstahl A, Wikstrom M. Oral Care
and Mortality in Older Adults with Pneumonia in Hospitals or Nursing
Homes: Systematic Review and Meta-Analysis. Journal of the
American Geriatrics Society. 2016;64(10):2109-2115.
83. Muller F. Oral hygiene reduces the mortality from aspiration
pneumonia in frail elders. Journal of dental research. 2015;94(3
Suppl):14s-16s.
84. Yokota T, Tachibana H, Konishi T, et al. Multicenter phase II study
of an oral care program for patients with head and neck cancer receiving
chemoradiotherapy. Supportive care in cancer : official journal of
the Multinational Association of Supportive Care in Cancer.2016;24(7):3029-3036.